EAF1
ELL-associated factor 1
Also known as: EAF1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JC9
- Gene
- EAF1
- Ensembl
- ENSG00000144597
- Chromosome
- 3
- Canonical length
- 268 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Vesicles
OverviewNCBI Gene
Enables transcription elongation factor activity. Involved in regulation of transcription elongation by RNA polymerase II. Located in intercellular bridge and nuclear body. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
268 residues, UniProt reviewed canonical sequence.
>Q96JC9|EAF1
1 MNGTANPLLD REEHCLRLGE SFEKRPRASF HTIRYDFKPA SIDTSCEGEL QVGKGDEVTI
61 TLPHIPGSTP PMTVFKGNKR PYQKDCVLII NHDTGEYVLE KLSSSIQVKK TRAEGSSKIQ
121 ARMEQQPTRP PQTSQPPPPP PPMPFRAPTK PPVGPKTSPL KDNPSPEPQL DDIKRELRAE
181 VDIIEQMSSS SGSSSSDSES SSGSDDDSSS SGGEDNGPAS PPQPSHQQPY NSRPAVANGT
241 SRPQGSNQLM NTLRNDLQLS ESGSDSDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EAF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 54 nTPM
- liver: 18 nTPM
- cerebral cortex: 13 nTPM
- adipose tissue: 12 nTPM
- parathyroid gland: 11 nTPM
- skin: 11 nTPM
Single-cell type
- late spermatids: 617 nCPM
- early spermatids: 350 nCPM
- monocytes: 124 nCPM
- kupffer cells: 64 nCPM
- monocyte progenitors: 59 nCPM
- neutrophils: 59 nCPM
Immune cell
- MAIT T-cell: 14 nTPM
- gdT-cell: 11 nTPM
- T-reg: 11 nTPM
- plasmacytoid DC: 9.8 nTPM
- memory CD4 T-cell: 9.2 nTPM
- naive CD8 T-cell: 8.7 nTPM
Brain region
- pons: 29 nTPM
- hypothalamus: 26 nTPM
- thalamus: 25 nTPM
- midbrain: 24 nTPM
- hippocampal formation: 24 nTPM
- medulla oblongata: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- -0.43
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- regulation of transcription elongation by RNA polymerase II
- transcription elongation by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EAF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EAF1 as an antibody target. Whether an autoantibody or antibody against EAF1 could matter depends on whether native EAF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EAF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EAF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...